Biopharmaceutical company Emergent BioSolutions Inc. spent $575,000 lobbying the federal government in the third quarter, according to a recent disclosure form.
The Rockville-based company lobbied on various agency appropriations and the government stockpiling of biodefense vaccines.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.